Sep 27, 2022 12:54 AM
BACK TO TOP
KSE100
41,151.54
531.33
(1.31%)
ALLSHR
28,129.42
298.27
(1.07%)
KSE30
15,419.88
206.94
(1.36%)
KMI30
67,329.27
1004.95
(1.52%)
BKTi
10,298.33
42.35
(0.41%)
OGTi
9,940.90
-28.32
(-0.28%)
KMIALLSHR
20,648.23
212.28
(1.04%)
PSXDIV20
13,467.90
102.65
(0.77%)
UPP9
10,465.81
110.45
(1.07%)
NITPGI
8,636.35
104.94
(1.23%)
NBPPGI
10,527.16
184.29
(1.78%)
MZNPI
8,567.48
151.44
(1.80%)
JSMFI
9,587.32
388.41
(4.22%)
ACI
8,265.20
211.99
(2.63%)
HBLTTI
10,136.46
22-09-2022
13.62
(0.13%)
Highnoon Laboratories Limited
PHARMACEUTICALS
Rs.529.97
1.98
(0.38%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Mon, Sep 26, 2022 3:36 PM
REG
FUT
ODL
Open
532.00
High
532.00
Low
521.36
Volume
5,100
CIRCUIT BREAKER
488.39 — 567.59
DAY RANGE
521.36 — 532.00
52-WEEK RANGE
502.00 — 651.50
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
527.99
VAR
13.50
HAIRCUT
25.00
P/E Ratio (TTM) **
10.09
1-Year Change *
-15.61%
YTD Change *
-15.59%

No record found

Open
525.50
High
528.75
Low
505.05
Close
527.50
Change
-0.09%
LDCP
527.99
Volume
28
Total Trades
22
CIRCUIT BREAKER
475.19 — 580.79
DAY RANGE
505.05 — 528.75
Ask Price
525.50
Ask Volume
1
Bid Price
525.00
Bid Volume
1
Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Highnoon Laboratories Limited was incorporated in Pakistan under the Companies Act, 2017. The Company is principally engaged in the manufacture, import, sale and marketing of pharmaceutical and allied consumer products.

KEY PEOPLE
Dr. Adeel Abbas HaideriCEO
Mr. Tausif Ahmad KhanChairman
Mr. Khadim Hussain MirzaCompany Secretary
ADDRESS

17.5 Kilometer Multan Road, Lahore.

WEBSITE

www.highnoon-labs.com

REGISTRAR

Corplink (Pvt) Ltd. Wings Arcade 1 K Commercial, Model Town, Lahore.

AUDITOR

EY Ford Rhodes Chartered Accountants.

Fiscal Year End

December

Equity Profile

Market Cap (000's)
22,197,308.53
Shares
41,884,085
Free Float
18,847,837
Free Float
45.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Aug 31, 2022Transmission of Quarterly Report for the period ended June 30,2022 View   PDF
Aug 15, 2022Financial Results for the half year ended June 30,2022 View   PDF
Apr 18, 2022Financial Results for the Quarter ended March 31,2022 View   PDF
Mar 29, 2022Transmission of Annual Report for the year ended December 31,2021 View   PDF
Mar 16, 2022Financial Results for the year ended December 31,2021 View   PDF
Oct 29, 2021Transmission of Quarterly Report for the period ended September 30,2021 View   PDF
Oct 22, 2021Financial Results for the Quarter ended September 30,2021 View   PDF
Aug 12, 2021Financial Results for 2nd Quarter View   PDF
Apr 29, 2021Transmission of Quarterly Report for the Period Ended 31 March 2021 View   PDF
Apr 29, 2021Financial Results for the Quarter Ended March 31, 2021 View   PDF
DateTitleDocument
Aug 5, 2022Board Meeting View   PDF
Apr 18, 2022Shareholders' Resolution at the 39th Annual General Meeting of the Company View   PDF
Apr 11, 2022Board Meeting View   PDF
Mar 28, 2022Notice of Annual General Meeting View   PDF
Mar 28, 2022Notice of Annual General Meeting View   PDF
Mar 9, 2022Board Meeting for Approval of Annual Accounts View   PDF
Oct 15, 2021Board Meeting for Approval of Quarterly Financials View   PDF
Sep 2, 2021Board Meeting for appointment of CEO View   PDF
Aug 5, 2021Board Meeting View   PDF
Apr 21, 2021Board Meeting View   PDF
DateTitleDocument
Sep 1, 2022Material Information View   PDF
Jun 16, 2022Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Jun 15, 2022Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations
REVOKED
View   
May 20, 2022Credit of Bonus Share Certifcates View   
May 9, 2022Transmission of Quarterly Report View   PDF
May 9, 2022Credit of Final Cash Dividend View   
Apr 11, 2022Material Information View   PDF
Mar 31, 2022Disclosure of Material Information View   PDF
Mar 17, 2022Issue Of Bonus Shares View   PDF
Dec 27, 2021Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2021202020192018
Sales13,000,78010,697,6349,047,6937,503,101
Profit after Taxation1,808,0331,420,736971,013725,891
EPS47.4841.0428.0523.07
Q2 2022Q1 2022Q3 2021Q2 2021
Sales4,327,6953,756,0343,209,5773,252,879
Profit after Taxation559,651533,700377,101441,007
EPS13.3614.029.9011.58
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2021202020192018
Gross Profit Margin (%)49.3547.8746.0046.65
Net Profit Margin (%)13.9113.2810.739.67
EPS Growth (%)15.6946.3121.59(5.95)
PEG0.840.320.89(2.53)

Payouts

DateFinancial ResultsDetailsBook Closure
March 16, 2022 3:48 PM31/12/2021(YR) 200% (D) - 10% (B) 11/04/2022 - 18/04/2022
March 25, 2021 4:01 PM31/12/2020(YR) 150%(F) (D) - 10% (B) 26/04/2021 - 27/04/2021
March 31, 2020 3:12 PM31/12/2019(YR) 130% (D) - 10% (B) 05/05/2020 - 12/05/2020
March 29, 2019 4:20 PM31/12/2018(YR) 130%(F) (D) - 10% (B) 23/04/2019 - 29/04/2019
March 9, 2018 3:55 PM31/12/2017(YR) 100% (D) - 12% (B) 12/04/2018 - 23/04/2018
March 16, 2017 3:45 PM31/12/2016(YR) 85% (D) - 12% (B) 21/04/2017 - 27/04/2017
March 15, 2016 3:38 PM31/12/2015(YR) 75% (D) - 12% (B) 14/04/2016 - 22/04/2016
March 20, 2015 3:49 PM31/12/2014(YR) 65% (D) - 12% (B) 17/04/2015 - 27/04/2015
March 18, 2014 2:49 PM31/12/2013(YR) 45% (D) 15/04/2014 - 24/04/2014
March 19, 2013 1:12 PM31/12/2012(YR) 35% (F) (D) 15/04/2013 - 23/04/2013

Financial Reports